Both in Lab Analytical Instruments
Bio-Rad Laboratories vs Bruker
Over the past year BIO returned +20.4% and BRKR returned +46.0%; their daily moves had a correlation of 0.47.
BIO +20.4% BRKR +46.0%Growth of $1, one year, split-adjusted
| Metric | BIO | BRKR |
|---|---|---|
| Price | $374.91 | $56.50 |
| Market cap | $10.02B | $8.61B |
| Today | +2.39% | +1.45% |
| 1 month | −1.3% | −11.5% |
| 6 months | +45.8% | +48.6% |
| Year to date | +23.7% | +19.9% |
| 1 year | +17.3% | +45.1% |
| Revenue growth (YoY) | −0.1% | +5.2% |
| Gross margin | 53.1% | 49.6% |
| Net margin | 57.1% | −7.5% |
| P/E (TTM) | 45.1× | — |
| Price / sales | 3.9× | 2.5× |
| Net cash | $414.8M | -$1.64B |
| Dividend yield | — | 0.35% |
| Volatility (60d) | 27.7% | 50.9% |
| Short % of float | 5.9% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).